Overview
Nevro is a publicly traded medical device company specializing in spinal cord stimulation therapy for chronic pain, best known for its HF10 high-frequency SCS platform that operates at 10 kHz to reduce paresthesia. Their devices are FDA-approved for treating intractable back and leg pain.
More in Neuromodulation
Latest industry news
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Target Brain Health
2026-07-11 · Funding
BrainCo Pushes to Commercialize Brain-Tech as China's BCI Ambitions Come Into Focus
2026-07-10 · Industry
FDA Clears PoNS Device for Stroke Rehabilitation, Broadening Neurostimulation's Clinical Reach
2026-07-09 · Policy
Neurovalens Wins FDA Approval for PTSD Therapy Targeting US Veterans
2026-07-08 · Policy
Company details
Category
⚡ Neuromodulation
Location
Redwood City, USA
Funding
Public · NYSE: NVRO
Website
www.nevro.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →